US 9404081
Pyruvate kinase activators for use in therapy
granted A61KA61K31/4965A61K31/497
Quick answer
US patent 9404081 (Pyruvate kinase activators for use in therapy) held by Agios Pharmaceuticals, Inc. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/4965, A61K31/497, A61P, A61P43/00